A Study About a Device that Measures Muscle Relaxation in Patients Receiving Muscle Relaxing Medications during Surgery

Overview

About this study

The aim of this study is to determine whether EMG monitoring in the operating room reduces the incidence of postoperative residual blockade (measured at the time of tracheal extubation and on arrival to the PACU).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

ASA I-III
Age 18-90
Presenting for surgery requiring maintenance of neuromuscular blockade in the operating room

Exclusion Criteria:

Presence of underlying neuromuscular disease
Use of drugs known to interfere with neuromuscular transmission (antiseizure medications; anticholinesterases, magnesium sulfate)
Renal insufficiency (serum creatinine < 1.8 mg/dL)
Renal failure

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator J Renew, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

J Renew, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials